bmiMD vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
bmiMD beats Gala overall, scoring 8/10 vs 7/10. Gala is more affordable at $149/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Gala for users who want low-cost compounded tirzepatide and a built-i.
A side-by-side comparison of bmiMD and Gala covering pricing, scores, medication types, insurance, and more to help you decide.
bmiMD
#9 of 42Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDGala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit Gala| Feature | bmiMD | Gala |
|---|---|---|
| Our Score | 8/10 | 7/10 |
| Starting Price | $319/mo | $149/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-first users who want affordable GLP-1 access | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging |
| Ranking | #9 | #40 |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
- −$29.99 shipping fee per order — most competitors include free shipping
- −$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Our Verdict
bmiMD edges out Gala with a score of 8/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to bmiMD's $319/mo. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging.